Overview

A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia

Status:
Completed

Trial end date:
2013-08-01

Target enrollment:

Participant gender:

Summary

This study will assess the safety, atorvastatin pharmacokinetics, and LDL-C lowering efficacy of ETC-1002 versus placebo in hypercholesterolemic subjects on background therapy of atorvastatin 10 mg.

Phase:

Phase 2

Details

Lead Sponsor:

Esperion Therapeutics
Esperion Therapeutics, Inc.

Treatments:

8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
Atorvastatin
Atorvastatin Calcium